dutogliptin: Clinical Trials

8 terminated, 2 completed, 1 unknown. 9 Phase 3, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	9	Terminated 7, Completed 1, Unknown 1
Phase 2	2	Completed 1, Terminated 1

Follow dutogliptin: new trials by email Literature Review of dutogliptin trials Research Report on dutogliptin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction Dutogliptin + Filgrastim, Placebo - ST Elevation Myocardial Infarction	Phase 3	Unknown	Recardio, Inc.	4100	2023-09-01	2023-06-05
Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction Dutogliptin Tartrate, Filgrastim Injectable Product, Placebos - Acute Myocardial Infarction, Acute Myocardial Ischemia	Phase 2	Completed	Recardio, Inc.	49	2018-12-07	2021-05-27
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone Dutogliptin, Sitagliptin - Diabetes Mellitus, Type 2	Phase 3	Terminated	Forest Laboratories	141	2010-03-01	2011-09-21
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin dutogliptin, sitagliptin - Type 2 Diabetes Mellitus	Phase 3	Terminated	Phenomix	650	2009-11-01	2010-08-11
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone Placebo, Dutogliptin - Diabetes Mellitus, Type II	Phase 3	Terminated	Forest Laboratories	252	2009-08-01	2011-09-21
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment dutogliptin, placebo, sitagliptin - Type 2 Diabetes Mellitus, Renal Impairment	Phase 3	Terminated	Phenomix	360	2009-08-01	2010-02-03
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin Dutogliptin, Placebo - Diabetes Mellitus, Type II	Phase 3	Terminated	Forest Laboratories	677	2009-07-01	2011-09-21
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin dutogliptin, placebo - Type 2 Diabetes Mellitus	Phase 3	Terminated	Phenomix	700	2009-05-01	2010-08-11
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus dutogliptin - Type 2 Diabetes Mellitus, Type 2 Diabetes	Phase 3	Terminated	Phenomix	450	2009-03-01	2010-08-11
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus PHX1149T, Placebo - Type 2 Diabetes Mellitus	Phase 3	Completed	Phenomix	480	2008-07-01	2010-04-13
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus dutogliptin - Type 2 Diabetes Mellitus	Phase 2	Terminated	Phenomix	339	2007-07-01	2010-08-11

Conditions studied

Diabetes Mellitus, Type 2 (9)  ·  Diabetes Mellitus (5)  ·  ST Elevation Myocardial Infarction (2)  ·  Renal Insufficiency (1)

Sponsors

Phenomix (6)  ·  Forest Laboratories (3)  ·  Recardio, Inc. (2)

Countries

United States (9)  ·  India (7)  ·  Argentina (5)  ·  Peru (5)  ·  Romania (4)  ·  Poland (3)  ·  Ukraine (3)  ·  Belarus (2)  ·  Czechia (2)  ·  Hungary (2)  ·  Lithuania (2)  ·  Malaysia (2)  ·  Philippines (2)  ·  Austria (1)  ·  Belgium (1)

Top investigators

Kaity Posada, PharmD (3)  ·  Roman Schenk, MD (1)